Eva is an M.D., D.Sci. and tenure Professor of Clinical Pharmacology. She has more than 10 years of clinical experience in medicine and has been Dean of Medical Faculty at Copenhagen University, Denmark. For the 89-98 decade, she was responsible for R&D in the pharmaceutical company H. Lundbeck A/S as Executive Vice President and member of the board of management. She made a turnaround of R&D, brought two compounds to market, and created a pipeline with compounds both in clinical development and drug discovery.
These accomplishments resulted in a very successful IPO in 1999. In 1998, she founded and managed as Chief Executive Officer Zealand Pharma A/S. Based on three patent applications, Zealand Pharma brought six compounds into development, three of which were out-licensed to Sanofi-Aventis and to Wyeth. In 2008, Eva Steiness founded as CEO newpharma.dk, a consultancy company offering management to biotech companies in which capacity she has served for Phlogo ApS, Serodus ASA, and Neoloch ApS.